The full content of Annals is available to subscribers

Subscribe/Learn More  >
Therapeutics |

Review: Hemoccult screening reduces death from colorectal cancer in average-risk patients > 50 years of age

Robert Fletcher, MD, MSc
[+] Article, Author, and Disclosure Information

Source of funding: Provincial and Territorial Ministries of Health and Health Canada.

For correspondence: The Canadian Task Force on Preventive Health Care, London, Ontario, Canada. E-mail ctf@ctfphc.org.

Ann Intern Med. 2002;136(3):91. doi:10.7326/ACPJC-2002-136-3-091
Text Size: A A A

Question: In asymptomatic patients at normal or above-average risk, how effective are specific screening techniques for colorectal cancer?

Data sources: Studies were identified by searching MEDLINE (1966 to January 2001), reviewing the references of reviews published before January 2001, and surveying content experts.

Study selection: English-language studies were selected if they evaluated Hemoccult testing, flexible sigmoidoscopy, or genetic testing as the first step in a multiphase secondary prevention strategy or colonoscopy as a single-phase secondary prevention strategy in both asymptomatic and high-risk patients. Studies that screened with digital rectal examination and double-contrast barium enema were excluded.

Data extraction: Data were extracted on patient characteristics, duration of follow-up, and main outcome measures.

Main results: For patients at average risk, evidence existed to support the use of annual or biennial fecal occult blood testing (FOBT) (from randomized controlled trials [RCTs]) for asymptomatic patients > 50 years of age. 4 RCTs assessed the value of screening with the Hemoccult test in average-risk patients and found that the risk for death from colorectal cancer was reduced with Hemoccult screening in patients > 50 years of age (relative risk reduction 16%, 95% CI 7 to 23, approximately 1 death from colorectal cancer would be averted for every 1000 screened over a 10-y period). Evidence for the effectiveness of flexible sigmoidoscopy in average-risk patients with an outcome of death was only available from case–control studies. 3 RCTs suggested that flexible sigmoidoscopy might be superior to FOBT in detecting adenomas and possible cancer. However, these trials were small. The evidence for whether 1 or both of FOBT and sigmoidoscopy should be done was unclear, as was the evidence about the use of colonoscopy as an initial screening test. For patients at above-average risk, low-quality evidence (retrospective cohort studies and case series) supported either genetic testing or flexible sigmoidoscopy of patients at risk in familial adenomatous polyposis kindreds and screening with colonoscopy of patients in kindreds with hereditary nonpolyposis colon cancer. The evidence regarding use of colonoscopy for persons who have a family history of colorectal polyps or cancer was unclear.

Conclusion: In patients > 50 years of age at average risk, Hemoccult screening reduces the risk for death from colorectal cancer.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $32.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.